Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

AIMS: Individualization of cancer chemotherapy based on the patient’s genetic makeup holds promise for reducing side effects and improving efficacy. However, the relative contribution of genetics to drug response is unknown. MATERIALS & METHODS: In this study, we investigated the cytotoxic effec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peters, Eric J, Motsinger-Reif, Alison, Havener, Tammy M, Everitt, Lorraine, Hardison, Nicholas E, Watson, Venita G, Wagner, Michael, Richards, Kristy L, Province, Mike A, McLeod, Howard L
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399590/
https://ncbi.nlm.nih.gov/pubmed/22008047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.11.92
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados